ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALR Alere Inc. (delisted)

50.99
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Alere Inc. (delisted) NYSE:ALR NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 50.99 0 00:00:00

Abbott Acquisition of Alere Set to Close on October 3, 2017

29/09/2017 2:26pm

PR Newswire (US)


Alere Inc. (delisted) (NYSE:ALR)
Historical Stock Chart


From Jan 2020 to Jan 2025

Click Here for more Alere Inc. (delisted) Charts.

WALTHAM, Mass., Sept. 29, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR) announced today that Abbott's acquisition of Alere is intended to close on October 3, 2017. The announcement follows receipt of all regulatory clearances necessary for closing.

Alere intends to request that the New York Stock Exchange cease trading of Alere's common stock before market open on October 3, 2017.

About Alere
Alere believes that when diagnosing and monitoring health conditions, Knowing now matters™. Alere delivers reliable and actionable information by providing rapid diagnostic tests, enhancing clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for cardiometabolic disease, infectious disease and toxicology.

For more information on Alere, please visit www.alere.com.

Cautionary Statement Regarding Forward-Looking Statements
This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. A number of important factors could cause actual results of Alere and its subsidiaries to differ materially from those indicated by such forward-looking statements, including the risk that the proposed merger with Abbott may not be completed, the risk factors detailed in Part I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended Dec. 31, 2016 (as filed with the SEC on June 5, 2017) and other risk factors identified from time to time in our periodic filings with the SEC. Readers should carefully review these risk factors, and should not place undue reliance on our forward-looking statements. These forward-looking statements are based on information, plans and estimates at the date of this communication. We undertake no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes.

View original content:http://www.prnewswire.com/news-releases/abbott-acquisition-of-alere-set-to-close-on-october-3-2017-300528261.html

SOURCE Alere Inc.

Copyright 2017 PR Newswire

1 Year Alere Inc. (delisted) Chart

1 Year Alere Inc. (delisted) Chart

1 Month Alere Inc. (delisted) Chart

1 Month Alere Inc. (delisted) Chart

Your Recent History

Delayed Upgrade Clock